$353 Million is the total value of Antipodean Advisors LLC's 9 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 62.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVNA | CARVANA COcl a | $122,124,000 | -0.1% | 405,000 | 0.0% | 34.58% | +2.7% | |
| SE | SEA LTDsponsord ads | $111,556,000 | +16.1% | 350,000 | 0.0% | 31.59% | +19.3% | |
| CDLX | CARDLYTICS INC | $53,621,000 | -33.9% | 638,800 | 0.0% | 15.18% | -32.0% | |
| CLVT | Sell | CLARIVATE PLC | $24,638,000 | -29.8% | 1,125,000 | -11.8% | 6.98% | -27.8% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $18,795,000 | +20.9% | 1,050,000 | +5.0% | 5.32% | +24.3% |
| New | ADAGIO THERAPEUTICS INC | $8,026,000 | – | 190,000 | +100.0% | 2.27% | – | |
| IBN | New | ICICI BANK LIMITEDadr | $7,548,000 | – | 400,000 | +100.0% | 2.14% | – |
| CMAX | CAREMAX INC | $5,796,000 | -25.0% | 600,000 | 0.0% | 1.64% | -22.8% | |
| NKLA | New | NIKOLA CORP | $1,067,000 | – | 100,000 | +100.0% | 0.30% | – |
| LMND | Exit | LEMONADE INC | $0 | – | -20,000 | -100.0% | -0.60% | – |
| CLOV | Exit | CLOVER HEALTH INVESTMENTS CO | $0 | – | -235,000 | -100.0% | -0.86% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARVANA CO | 21 | Q2 2023 | 38.5% |
| AMAZON COM INC | 20 | Q4 2020 | 33.8% |
| SEA LTD | 19 | Q3 2023 | 60.8% |
| CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
| MEDICINES CO | 18 | Q4 2019 | 19.8% |
| ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
| CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
| HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
| CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
| EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.